Cite
HARVARD Citation
Stranzenbach, R. et al. (2018). Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T‐cell lymphoma: reply from the authors. British journal of dermatology. p. 303. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stranzenbach, R. et al. (2018). Alternate dosing regimens of brentuximab vedotin for CD30+ cutaneous T‐cell lymphoma: reply from the authors. British journal of dermatology. p. 303. [Online].